Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients

British Journal of Cancer

Volumn 113, Issue 1, 2015, Pages 76-82

  Summerer, I ^a   Unger, K ^a   Braselmann, H ^a   Schuettrumpf, L ^a,b   Maihoefer, C ^a,b   Baumeister, P ^a,b   Kirchner, T ^b   Niyazi, M ^a,b   Sage, E ^c   Specht, H M ^c   Multhoff, G ^a,c   Moertl, S ^a   Belka, C ^a,b   Zitzelsberger, H ^a  

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

biomarker; circulating non coding RNA; Head and neck cancer; prognosis; radiochemotherapy; radiotherapy outcome

Indexed keywords

BIOLOGICAL MARKER; CISPLATIN; FLUOROURACIL; MICRORNA; MICRORNA 142 3P; MICRORNA 186 5P; MICRORNA 191 5P; MICRORNA 195 5P; MICRORNA 197 3P; MICRORNA 21 5P; MICRORNA 28 3P; MICRORNA 374B 5P; MICRORNA 425 5P; MICRORNA 574 3P; MICRORNA 590 5P; MITOMYCIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GENE EXPRESSION; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; HUMAN TISSUE; HYPOPHARYNX CARCINOMA; LARYNX SQUAMOUS CELL CARCINOMA; MALE; MAXILLA SINUS CARCINOMA; MIDDLE AGED; MOUTH SQUAMOUS CELL CARCINOMA; MULTIMODALITY CANCER THERAPY; NASOPHARYNX CARCINOMA; OROPHARYNX CARCINOMA; OUTCOME ASSESSMENT; PARANASAL SINUS CARCINOMA; PLASMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; VERY ELDERLY; BLOOD; CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION PROFILING; GENETICS; HEAD AND NECK NEOPLASMS; METABOLISM; PROGNOSIS;

AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; GENE EXPRESSION PROFILING; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84934444721     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2015.111     Document Type: Article

References (36)

1. The R Project for Statistical Computing (2014). Available at www.r-project.org.
2. Adelstein DJ, Li Y, Adams GL, Wagner Jr H, Kish JA, Ensley JF, Schuller DE, Forastiere AA (2003) An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer. J Clin Oncol 21: 92-98.
3. Argiris A, Karamouzis MV, Raben D, Ferris RL (2008) Head and neck cancer. Lancet 371: 1695-1709.
4. Bledsoe T, Noble A, Hunter G, Rybicki L, Hoschar A, Chute D, Saxton J, Greskovich J, Adelstein D, Koyfman S (2013) Oropharyngeal squamous cell carcinoma with known human papillomavirus status treated with definitive chemoradiotherapy: patterns of failure and toxicity outcomes. Radiat Oncol 8: 174.
5. Blot WJ, Mclaughlin JK, Winn DM, Austin DF, Greenberg RS, Preston-Martin S, Bernstein L, Schoenberg JB, Stemhagen A, Fraumeni Jr JF (1988) Smoking and drinking in relation to oral and pharyngeal cancer. Cancer Res 48: 3282-3287.
6. Cai J, Wu J, Zhang H, Fang L, Huang Y, Yang Y, Zhu X, Li R, Li M (2013) miR-186 downregulation correlates with poor survival in lung adenocarcinoma, where it interferes with cell-cycle regulation. Cancer Res 73: 756-766.
7. D'souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML (2007) Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med 356: 1944-1956.
8. Fleming NH, Zhong J, Da Silva IP, Vega-Saenz De Miera E, Brady B, Han SW, Hanniford D, Wang J, Shapiro RL, Hernando E, Osman I (2014) Serum-based miRNAs in the prediction and detection of recurrence in melanoma patients. Cancer 121(1): 51-59.
9. Gehrmann M, Specht HM, Bayer C, Brandstetter M, Chizzali B, Duma M, Breuninger S, Hube K, Lehnerer S, Van Phi V, Sage E, Schmid TE, Sedelmayr M, Schilling D, Sievert W, Stangl S, Multhoff G (2014) Hsp70-a biomarker for tumor detection and monitoring of outcome of radiation therapy in patients with squamous cell carcinoma of the head and neck. Radiat Oncol 9: 131.
10. He HC, Han ZD, Dai QS, Ling XH, Fu X, Lin ZY, Deng YH, Qin GQ, Cai C, Chen JH, Jiang FN, Liu X, Zhong WD (2013) Global analysis of the differentially expressed miRNAs of prostate cancer in Chinese patients. BMC Genomics 14: 757.
11. Healy NA, Heneghan HM, Miller N, Osborne CK, Schiff R, Kerin MJ (2012) Systemic mirnas as potential biomarkers for malignancy. Int J Cancer 131: 2215-2222.
12. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ (2010) Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 251: 499-505.
13. Hoffmann TK (2012) Systemic therapy strategies for head-neck carcinomas: current status. GMS Curr Top Otorhinolaryngol Head Neck Surg 11: 03.
14. Hotchi M, Shimada M, Kurita N, Iwata T, Sato H, Morimoto S, Yoshikawa K, Higashijima J, Miyatani T (2013) microRNA expression is able to predict response to chemoradiotherapy in rectal cancer. Mol Clin Oncol 1: 137-142.
15. Igglezou M, Vareli K, Georgiou GK, Sainis I, Briasoulis E (2014) Kinetics of circulating levels of miR-195, miR-155 and miR-21 in patients with breast cancer undergoing mastectomy. Anticancer Res 34: 7443-7447.
16. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS, Harris AL (2008) Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 141: 672-675.
17. Li J, Huang H, Sun L, Yang M, Pan C, Chen W, Wu D, Lin Z, Zeng C, Yao Y, Zhang P, Song E (2009) MiR-21 indicates poor prognosis in tongue squamous cell carcinomas as an apoptosis inhibitor. Clin Cancer Res 15: 3998-4008.
18. Licitra L, Perrone F, Bossi P, Suardi S, Mariani L, Artusi R, Oggionni M, Rossini C, Cantù G, Squadrelli M, Quattrone P, Locati LD, Bergamini C, Olmi P, Pierotti MA, Pilotti S (2006) High-risk human papillomavirus affects prognosis in patients with surgically treated oropharyngeal squamous cell carcinoma. J Clin Oncol 24: 5630-5636.
19. Lin R-J, Xiao D-W, Liao L-D, Chen T, Xie Z-F, Huang W-Z, Wang W-S, Jiang T-F, Wu B-L, Li E-M, Xu L-Y (2012) MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J Surg Oncol 105: 175-182.
20. Liu SG, Qin XG, Zhao BS, Qi B, Yao WJ, Wang TY, Li HC, Wu XN (2013) Differential expression of miRNAs in esophageal cancer tissue. Oncol Lett 5: 1639-1642.
21. Lv M, Zhang X, Jia H, Li D, Zhang B, Zhang H, Hong M, Jiang T, Jiang Q, Lu J, Huang X, Huang B (2012) An oncogenic role of miR-142-3p in human T-cell acute lymphoblastic leukemia (T-ALL) by targeting glucocorticoid receptor-alpha and cAMP/PKA pathways. Leukemia 26: 769-777.
22. Manterola L, Guruceaga E, Pérez-Larraya JG, González-Huarriz M, Jauregui P, Tejada S, Diez-Valle R, Segura V, Samprón N, Barrena C, Ruiz I, Agirre A, Ayuso Á , Rodrguez J, González Á , Xipell E, Matheu A, López De Munain A, Tunõń T, Zazpe I, Garc?á-Foncillas J, Paris S, Delattre JY, Alonso MM (2014) A small noncoding RNA signature found in exosomes of GBM patient serum as a diagnostic tool. Neuro Oncol 16: 520-527.
23. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB, Tewari M (2008) Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci 105: 10513-10518.
24. Nagpal N, Kulshreshtha R (2014) miR-191: an emerging player in disease biology. Front Genet 5: 99.
25. Nohata N, Hanazawa T, Kikkawa N, Mutallip M, Sakurai D, Fujimura L, Kawakami K, Chiyomaru T, Yoshino H, Enokida H, Nakagawa M, Okamoto Y, Seki N (2011) Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC). J Hum Genet 56: 595-601.
26. Selth LA, Tilley WD, Butler LM (2012) Circulating microRNAs: macro-utility as markers of prostate cancer? Endocr Relat Cancer 19: R99-R113.
27. Sethi S, Ali S, Philip P, Sarkar F (2013) Clinical advances in molecular biomarkers for cancer diagnosis and therapy. Int J Mol Sci 14: 14771-14784.
28. Summerer I, Niyazi M, Unger K, Pitea A, Zangen V, Hess J, Atkinson M, Belka C, Moertl S, Zitzelsberger H (2013) Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients. Radiat Oncol 8: 296.
29. Sun N, Ye L, Chang T, Li X, Li X (2014) microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma. Int J Clin Exp Pathol 7: 6871-6879.
30. Tsujiura M, Ichikawa D, Komatsu S, Shiozaki A, Takeshita H, Kosuga T, Konishi H, Morimura R, Deguchi K, Fujiwara H, Okamoto K, Otsuji E (2010) Circulating microRNAs in plasma of patients with gastric cancers. Br J Cancer 102: 1174-1179.
31. Tuyns AJ, Esteve J, Raymond L, Berrino F, Benhamou E, Blanchet F, Boffetta P, Crosignani P, Del Moral A, Lehmann W, Merletti F, Pequignot G, Riboli E, Sancho-Garnier H, Terracini B, Zubiri A, Zubiri L (1988) Cancer of the larynx/hypopharynx, tobacco and alcohol: IARC international case-control study in Turin and Varese (Italy), Zaragoza and Navarra (Spain), Geneva (Switzerland) and Calvados (France). Int J Cancer 41: 483-491.
32. Ujihira T, Ikeda K, Suzuki T, Yamaga R, Sato W, Horie-Inoue K, Shigekawa T, Osaki A, Saeki T, Okamoto K, Takeda S, Inoue S (2015) MicroRNA-574-3p, identified by microRNA library-based functional screening, modulates tamoxifen response in breast cancer. Sci Rep 5: 7641.
33. Xiao-Chun W, Wei W, Zhu-Bo Z, Jing Z, Xiao-Gang T, Jian-Chao L (2013) Overexpression of miRNA-21 promotes radiation-resistance of non-small cell lung cancer. Radiat Oncol 8: 146.
34. Zhao BS, Liu SG, Wang TY, Ji YH, Qi B, Tao YP, Li HC, Wu XN (2013) Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac J Cancer Prev 14: 139-143.
35. Zheng J, Xue H, Wang T, Jiang Y, Liu B, Li J, Liu Y, Wang W, Zhang B, Sun M (2011) miR-21 downregulates the tumor suppressor P12CDK2AP1 and stimulates cell proliferation and invasion. J Cell Biochem 112: 872-880.
36. Zhu W, Xu B (2014) MicroRNA-21 Identified as predictor of cancer outcome: a meta-analysis. PLoS One 9: e103373.